Assessment of physicians’ adherence to guideline-directed medical therapy among patients with heart failure with reduced ejection fraction at the University of Gondar Comprehensive Specialized Hospital, Northwest, Ethiopia, 2023
{"title":"Assessment of physicians’ adherence to guideline-directed medical therapy among patients with heart failure with reduced ejection fraction at the University of Gondar Comprehensive Specialized Hospital, Northwest, Ethiopia, 2023","authors":"Sisay Sitotaw Anberbr MSc , Ousman Abubeker Abdela MSc , Alemneh Ayu Biyazin MSc , Gebremariam Wulie Geremew MSc , Adane Desta Getahun MSc , Getachew Yitayew Tarekegn MSc , Agegnehu Derbew Teshager MD , Masho Tigabe Tekle MSc","doi":"10.1016/j.hroo.2025.06.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Adhering well to guideline-directed medical therapy (GDMT) is essential for improving treatment outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Despite its significance, studies on the status of GDMT adherence in patients with HF in Ethiopia are scarce.</div></div><div><h3>Objective</h3><div>This study aimed to assess physicians’ adherence to GDMT and the associated factors in patients with HFrEF.</div></div><div><h3>Methods</h3><div>A retrospective follow-up study was conducted from September 1, 2018, to July 31, 2023. Quality of Adherence to Guideline Recommendations for Lifesaving Treatment in Heart Failure Survey scores were used to assess physicians’ adherence to GDMT. SPSS version 27.0 was used for analysis, and multinomial logistic regression analysis was performed.</div></div><div><h3>Results</h3><div>The Quality of Adherence to Guideline Recommendations for Lifesaving Treatment in Heart Failure Survey scores showed that the physicians’ adherence to GDMT was good in 40% (95% confidence interval [CI] 35.30–44.90), moderate in 33.8% (95% CI 29.3–38.6), and poor in 26.2% of the study participants (95% CI 22–30.7). Age of ≥65 years (adjusted odds ratio [AOR] 0.14, 95% CI 0.07–0.29); causes of HF such as ischemic heart disease (AOR 16, 95% CI 6.75–37.90), valvular heart disease (AOR 5.3, 95% CI 2.58–10.92), dilated cardiomyopathy (AOR 8.24, 95% CI 3.97–17.09), and hypertension (AOR 6.62, 95% CI 2.98–14.69); and duration of HFrEF of ≥3 years (AOR 2.59, 95% CI 1.32–5.08) were factors significantly associated with good physicians’ adherence to GDMT.</div></div><div><h3>Conclusion</h3><div>The use of all indicated medications as per the guideline recommendation for HFrEF was low, and most patients received suboptimal doses of GDMT. Particularly, the beta-blocker dose was very suboptimal. Encouraging healthcare provider training, access to separate cardiac clinics and cardiologists, following guidelines, timely patient appointments, and medication availability are recommended for better clinical outcomes.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"6 9","pages":"Pages 1435-1447"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Rhythm O2","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666501825002351","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Adhering well to guideline-directed medical therapy (GDMT) is essential for improving treatment outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Despite its significance, studies on the status of GDMT adherence in patients with HF in Ethiopia are scarce.
Objective
This study aimed to assess physicians’ adherence to GDMT and the associated factors in patients with HFrEF.
Methods
A retrospective follow-up study was conducted from September 1, 2018, to July 31, 2023. Quality of Adherence to Guideline Recommendations for Lifesaving Treatment in Heart Failure Survey scores were used to assess physicians’ adherence to GDMT. SPSS version 27.0 was used for analysis, and multinomial logistic regression analysis was performed.
Results
The Quality of Adherence to Guideline Recommendations for Lifesaving Treatment in Heart Failure Survey scores showed that the physicians’ adherence to GDMT was good in 40% (95% confidence interval [CI] 35.30–44.90), moderate in 33.8% (95% CI 29.3–38.6), and poor in 26.2% of the study participants (95% CI 22–30.7). Age of ≥65 years (adjusted odds ratio [AOR] 0.14, 95% CI 0.07–0.29); causes of HF such as ischemic heart disease (AOR 16, 95% CI 6.75–37.90), valvular heart disease (AOR 5.3, 95% CI 2.58–10.92), dilated cardiomyopathy (AOR 8.24, 95% CI 3.97–17.09), and hypertension (AOR 6.62, 95% CI 2.98–14.69); and duration of HFrEF of ≥3 years (AOR 2.59, 95% CI 1.32–5.08) were factors significantly associated with good physicians’ adherence to GDMT.
Conclusion
The use of all indicated medications as per the guideline recommendation for HFrEF was low, and most patients received suboptimal doses of GDMT. Particularly, the beta-blocker dose was very suboptimal. Encouraging healthcare provider training, access to separate cardiac clinics and cardiologists, following guidelines, timely patient appointments, and medication availability are recommended for better clinical outcomes.
背景:严格遵守指导药物治疗(GDMT)对于改善心力衰竭(HF)伴射血分数降低(HFrEF)患者的治疗效果至关重要。尽管具有重要意义,但关于埃塞俄比亚HF患者GDMT依从性的研究很少。目的本研究旨在评估医生在HFrEF患者中对GDMT的依从性及其相关因素。方法于2018年9月1日至2023年7月31日进行回顾性随访研究。对心力衰竭救命治疗指南建议的依从性使用调查得分来评估医生对GDMT的依从性。采用SPSS 27.0版进行分析,采用多项logistic回归分析。结果对心力衰竭救命治疗指南建议的依从性调查得分显示,医生对GDMT的依从性为良好的占40%(95%可信区间[CI] 35.30-44.90),中等的占33.8% (95% CI 29.3-38.6),较差的占26.2% (95% CI 22-30.7)。年龄≥65岁(校正优势比[AOR] 0.14, 95% CI 0.07-0.29);HF的病因包括缺血性心脏病(AOR 16, 95% CI 6.75-37.90)、瓣膜性心脏病(AOR 5.3, 95% CI 2.58-10.92)、扩张性心肌病(AOR 8.24, 95% CI 3.97-17.09)和高血压(AOR 6.62, 95% CI 2.98-14.69);HFrEF持续时间≥3年(AOR 2.59, 95% CI 1.32-5.08)是与好医生坚持GDMT显著相关的因素。结论HFrEF指南推荐的所有适应症药物的使用率较低,大多数患者接受了次优剂量的GDMT。特别是,受体阻滞剂的剂量非常不理想。为了获得更好的临床结果,建议鼓励对医疗保健提供者进行培训、访问单独的心脏病诊所和心脏病专家、遵循指导方针、及时预约患者和提供药物。